Evidence map›Paper›PMID 27866924›Full record

ReviewTrends in molecular medicine2016

Bacterial Pathogens versus Autophagy: Implications for Therapeutic Interventions.

Jacqueline M Kimmey, Christina L Stallings

Abstract readReview
In one paragraph

Review in Trends in molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Restricting intracellularAutophagy · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. HEATR3 recognizes membrane rupture and facilitates xenophagy in response toProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. EnterohemorrhagicAIMS microbiology · 2025
    Article
  14. Article
  15. Fenofibrate suppressesFrontiers in cellular and infection microbiology · 2025
    Article
  16. Autophagy and Bacterial infections.Autophagy reports · 2025
    Review
  17. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  18. Article
  19. Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jacqueline M KimmeyDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Christina L StallingsDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: stallings@wustl.edu.

Funding

TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Targeting a New Essential Virulence Mechanism in Drug-Resistant MycobacteriaR33AI111696 · NIAID · WASHINGTON UNIVERSITY · PI STALLINGS, CHRISTINA LEIGH · 2016 to 2018
$1.4M
Targeting a New Essential Virulence Mechanism in Drug-Resistant MycobacteriaR21AI111696 · NIAID · WASHINGTON UNIVERSITY · PI STALLINGS, CHRISTINA LEIGH · 2014 to 2015
$426k
NIAID NIH HHS R21 AI111696NIAID NIH HHS R33 AI111696NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

Research in recent years has focused significantly on the role of selective macroautophagy in targeting intracellular pathogens for lysosomal degradation, a process termed xenophagy. In this review we evaluate the proposed roles for xenophagy in controlling bacterial infection, highlighting the concept that successful pathogens have evolved ways to subvert or exploit this defense, minimizing the actual effectiveness of xenophagy in innate immunity. Instead, studies in animal models have revealed that autophagy-associated proteins often function outside of xenophagy to influence bacterial pathogenesis. In light of current efforts to manipulate autophagy and the development of host-directed therapies to fight bacterial infections, we also discuss the implications stemming from the complicated relationship that exists between autophagy and bacterial pathogens.

Indexed as

AutophagyImmunity, InnateAnimalsAnti-Bacterial AgentsAutophagy-Related ProteinsBacteriaBacterial InfectionsBacterial Physiological PhenomenaDrug DiscoveryHost-Pathogen InteractionsHumansMycobacterium tuberculosisTuberculosisAnti-Bacterial AgentsAutophagy-Related Proteinsautophagybacterial pathogenshost-directed therapiesMycobacterium tuberculosisxenophagy

Identifiers

PMID27866924
PMCPMC5215815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.